Dianthus Therapeutics reported $761K in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 21.7M 4.09M Jun/2026
Celltrion KRW 1.24T 90B Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 761K 298K Jun/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Moderna USD 1.31M 98.69M Sep/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Organigram Holdings CAD 105.78M 45.99M Jun/2026
Organon & Co USD 1.57B 10M Sep/2026
Pharma Mar EUR 54.2M 4.2M Sep/2026
Qiagen NV USD 487.78M 24.66M Sep/2026
Revvity USD 729M 680K Sep/2026
Sartorius EUR 926.3M 14.5M Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
Tectonic Therapeutic USD 0 0 Dec/2024
Tilray USD 217.51M 74.75M Dec/2025
Viatris USD 3.75B 10M Sep/2026
Xeris Pharmaceuticals USD 92.1M 8.97M Jun/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026